Subthreshold Micropulse Laser for Eyes: With Center Involving Diabetic Macular Edema With Good Visual Acuity: The PULSE Study, a Randomized Clinical Trial
In eyes with center-involved DME and good VA, SML did not prevent or delay the vision loss threshold for initiating anti-VEGF therapy. However, these results may be affected by a high rate of early participant dropout from the study. <b>[<i>Ophthalmic Surg Lasers Imaging Retina</i> 2025;56:86-93.]</b>.
Authors
- Glenn Yiu (ORCID: https://orcid.org/0000-0003-3061-3310)
- Susanna S. Park (ORCID: https://orcid.org/0000-0001-5911-6671)
- Machelle Wilson (ORCID: https://orcid.org/0000-0003-1734-2755)
- Samuel Feldman
- Ala Moshiri (ORCID: https://orcid.org/0000-0002-4277-8094)
- Yunyi Ren
- Jesse Basra
- Anjola Lawani
Institutions
- University of California, Davis (US)
Publication Details
- Journal
- Ophthalmic surgery, lasers & imaging retina
- Published
- 2024-11-13
- DOI
- https://doi.org/10.3928/23258160-20240924-03
- Citations
- 2
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.08
Funders
- U.S. Department of Defense
- Alimera Sciences
- National Institutes of Health
- Allergan
- National Center for Advancing Translational Sciences